We are live on
!
Find out more
Macquarie Group Portfolio holdings
AUM
$23.2B
Turnover
20.23%
1-Year Est. Return
40.19%
This Fund
S&P 500
This Quarter
Est. Return
-0.1%
1 Year Est. Return
+40.19%
3 Year Est. Return
+109.35%
5 Year Est. Return
+140.11%
10 Year Est. Return
+481.97%
AUM
$16.8B
AUM Growth
-$6.11B
(-27%)
Cap. Flow
-$5.47B
Cap. Flow
% of AUM
-32.61%
Top 10 Holdings %
Top 10 Hldgs %
32.92%
Holding
893
New
48
Increased
160
Reduced
557
Closed
80
Avg Time Held Equity + Options
9.2
years
Top 10 Avg Time Held Equity + Options
2
years
Top 20 Avg Time Held Equity + Options
1.5
years
Avg Time Held Equity only
9.2
years
Top 10 Avg Time Held Equity only
2
years
Top 20 Avg Time Held Equity only
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$776M |
| 2 |
DexCom
DXCM
|
+$43.3M |
| 3 |
Cisco
CSCO
|
+$33.1M |
| 4 |
James Hardie Industries
JHX
|
+$30.3M |
| 5 |
General Dynamics
GD
|
+$29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.16B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$541M |
| 3 |
NVIDIA
NVDA
|
+$476M |
| 4 |
Apple
AAPL
|
+$317M |
| 5 |
Microsoft
MSFT
|
+$307M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.42% |
| 2 | Miscellaneous | 15.51% |
| 3 | Financials | 9.57% |
| 4 | Communication Services | 8.46% |
| 5 | Healthcare | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
PPL Corp
PPL
$26.5B
| $21.2M | 0.13% |
554,945
+24,907
| +5% | +$919K |
2013 Q2
51 quarters
|
|
152
ResMed
RMD
$33.6B
| $20.1M | 0.12% |
89,565
-40,777
| -31% | -$10.2M |
2013 Q2
51 quarters
|
|
153
Evercore
EVR
$9.77B
| $19.9M | 0.12% |
66,537
-133,959
| -67% | -$43.9M |
2013 Q2
51 quarters
|
|
154
Walt Disney
DIS
$191B
| $19.8M | 0.12% |
205,870
-106,836
| -34% | -$11.3M |
2013 Q2
51 quarters
|
|
155
Crown Castle
CCI
$35B
| $19.8M | 0.12% |
243,860
-35,624
| -13% | -$3.07M |
2013 Q2
51 quarters
|
|
156
Thermo Fisher Scientific
TMO
$255B
| $19.8M | 0.12% |
40,260
-20,339
| -34% | -$11M |
2013 Q2
51 quarters
|
|
157
Abbott
ABT
$181B
| $19.8M | 0.12% |
192,989
-103,475
| -35% | -$11.7M |
2013 Q2
51 quarters
|
|
158
Intel
INTC
$475B
| $19.8M | 0.12% |
447,953
-336,060
| -43% | -$15.4M |
2013 Q2
51 quarters
|
|
159
Ameren
AEE
$29.4B
| $19.4M | 0.12% |
176,827
-6,030
| -3% | -$645K |
2013 Q2
51 quarters
|
|
160
MetLife
MET
$64B
| $18.9M | 0.11% |
267,877
-35,758
| -12% | -$2.68M |
2013 Q2
51 quarters
|
|
161
Atmos Energy
ATO
$28.3B
| $18.9M | 0.11% |
102,512
-3,591
| -3% | -$635K |
2015 Q1
44 quarters
|
|
162
FirstEnergy
FE
$26.7B
| $18.9M | 0.11% |
373,321
+9,876
| +3% | +$479K |
2013 Q2
51 quarters
|
|
163
Microchip Technology
MCHP
$40.1B
| $18.5M | 0.11% |
286,002
+220,523
| +337% | +$15.9M |
2013 Q2
51 quarters
|
|
164
Medtronic
MDT
$121B
| $18.5M | 0.11% |
213,220
-228,747
| -52% | -$21.9M |
2013 Q2
51 quarters
|
|
165
ConocoPhillips
COP
$176B
| $18.5M | 0.11% |
139,877
-5,687
| -4% | -$630K |
2013 Q2
51 quarters
|
|
166
Analog Devices
ADI
$192B
| $18M | 0.11% |
56,654
-21,247
| -27% | -$6.76M |
2013 Q2
51 quarters
|
|
167
Vertex Pharmaceuticals
VRTX
$127B
| $18M | 0.11% |
40,236
-4,500
| -10% | -$2.1M |
2013 Q2
51 quarters
|
|
168
Texas Instruments
TXN
$252B
| $17.8M | 0.11% |
91,902
-119,801
| -57% | -$24.3M |
2013 Q2
51 quarters
|
|
169
CenterPoint Energy
CNP
$26.7B
| $17.6M | 0.1% |
407,446
-17,136
| -4% | -$707K |
2013 Q2
51 quarters
|
|
170
Eversource Energy
ES
$25.2B
| $17.6M | 0.1% |
253,485
-3,685
| -1% | -$260K |
2013 Q2
51 quarters
|
|
171
Bausch Health
BHC
$2.36B
| $17.6M | 0.1% |
3,250,000
| – | – |
2024 Q3
6 quarters
|
|
172
Align Technology
ALGN
$10.5B
| $17.5M | 0.1% |
102,202
+99,318
| +3,444% | +$17.4M |
2013 Q2
51 quarters
|
|
173
Intuitive Surgical
ISRG
$151B
| $16.8M | 0.1% |
36,502
-22,271
| -38% | -$11.3M |
2013 Q2
51 quarters
|
|
174
Uber
UBER
$144B
| $16.7M | 0.1% |
231,671
-52,801
| -19% | -$4.06M |
2019 Q2
27 quarters
|
|
175
Intuit
INTU
$86.9B
| $16.4M | 0.1% |
38,062
-47,468
| -55% | -$22.6M |
2013 Q2
51 quarters
|
|
Similar funds
Macquarie Group's Q1 2026 Portfolio in Review
As of Q1 2026, Macquarie Group held 893 positions worth $16.8B, down 27% from $22.9B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Macquarie Group withdrew a net $5.47B in Q1 2026, closing 80 positions and reducing 557 holdings. Its most notable exit was Janus Henderson, an estimated $8.79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, Macquarie Group opened a new position in James Hardie Industries worth $25.5M.
- Macquarie Group's largest Q1 2026 buy was James Hardie Industries: 1,347,770 shares worth $25.5M.
- Macquarie Group added most to State Street SPDR S&P 500 ETF Trust in Q1 2026, an estimated $776M increase.
- Macquarie Group's biggest Q1 2026 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.16B.
- Macquarie Group fully exited Janus Henderson in Q1 2026, selling an estimated $8.79M.
- Macquarie Group's ten largest holdings make up 33% of its $16.8B portfolio in Q1 2026.
- Macquarie Group opened 48 new positions and closed 80 in Q1 2026.
- Macquarie Group's portfolio value fell 27% quarter-over-quarter to $16.8B.
Based on Macquarie Group's 13F filing for Q1 2026, filed 15 May 2026.